This site is new - feedback and suggestions welcome via GitHub issues.

#myeloma — Wednesday, July 22, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 FcRH5xCD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial. (nature.com) robot Cohen AD … Krishnan A Nature Medicine 2026-07-22 #immunotherapy #myeloma #bispecific-antibodies #clinical trial #oncology